Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant Prescription.

Current drug metabolism - 1 Jan 2015

Lloret-Linares Celia, Bellivier Frank, Haffen Emmanuel, Aubry Jean-Michel, Daali Youssef, Heron Kyle, Berney Patricia, Desmeules Jules, Besson Marie

Abstract excerpt

The development of a personalized psychopharmacotherapy could potentially reduce treatment failure associated with drug intolerance or resistance, and therefore the burden and costs of affective disorders. An important challenge in realising this potential will be to identify suitable markers of an individual's metabolic response to specific pharmaceuticals. In the absence of suitable markers related directly to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Monitoring

Share to Genetic Variation

Share to Phenotype

Share to Precision Medicine

Source

Identifiers

PMID: 26152128
DOI: 10.2174/138920021601150702160728

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant Prescription.PMID 26152128Read ↗

Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.Semantic proximity Read ↗

[Pharmacogenetics or the promise of a personalized medicine: variability in drug metabolism and transport].Semantic proximity Read ↗

Pharmacogenetics and antipsychotics in the light of personalized pharmacotherapy.Semantic proximity Read ↗

The Influence of Genetic Variations and Drug Interactions Based on Metabolism of Antidepressants and Anticonvulsants.Semantic proximity Read ↗

[The value of pharmacogenetic tests in antidepressive medication therapy].Semantic proximity Read ↗

[Characterisation of selected molecular mechanisms influencing pharmacokinetics and pharmacodynamics of antidepressants].Semantic proximity Read ↗

Therapeutic monitoring of antidepressants in the era of pharmacogenetics studies.Semantic proximity Read ↗

Phenotyping and genotyping of drug metabolism to guide pharmacotherapy in psychiatry.Semantic proximity Read ↗

Pharmacogenomics and antidepressant drugs.Semantic proximity Read ↗

Pharmacogenomics of antidepressant drugs.Semantic proximity Read ↗

The impact of CYP allelic variation on antidepressant metabolism: a review.Semantic proximity Read ↗

Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.